31 Mar. 2016
WILMINGTON, N.C., (March 31, 2016) – Pharmaceutical Product Development, LLC (PPD) today announced it was named the Best Contract Research Organization (CRO) at the 9th Vaccine Industry Excellence Awards at the World Vaccine Congress 2016. The ViE awards celebrate the outstanding achievements of leaders who continually set standards of excellence and advocacy in the vaccine industry.
“We are honored to receive this award acknowledging PPD’s contributions in helping our customers bring life-changing vaccines to patients more quickly and with the highest standards of quality,” said Bill Sharbaugh, PPD’s chief operating officer. “PPD has more than 25 years of experience in providing a full range of vaccine testing services. This honor recognizes the expertise of our dedicated team members, who are experts and thought leaders in their individual disciplines and involved in establishing best practices for national and international regulatory organizations.”
PPD’s service offerings span the value chain of clinical research, with integrated Phase I-IV services and PPD®Laboratories, offering the most comprehensive lab services available in the industry.
PPD Laboratories’ vaccines sciences lab has worked on 12 vaccines approved by regulators and is a leader in comprehensive development and testing services of vaccines. With state-of-the-art facilities and instrumentation, PPD’s vaccine sciences lab helps customers realize the highest scientific standards for their programs, with a focus on cost efficiencies to speed the introduction of life-changing vaccines.
The World Vaccine Congress is an annual gathering of the global vaccine industry to discuss commercial and scientific issues involving regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 15,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.